68Ga-DOTATATE PET/CT Uptake in Prostate With an Incidental Finding of Prostatic Acinar Adenocarcinoma and Metastatic Neuroendocrine Cancer to the Liver

Clin Nucl Med. 2021 Aug 1;46(8):e428-e430. doi: 10.1097/RLU.0000000000003721.

Abstract

A 69-year-old man with history of metastatic neuroendocrine tumor presented for initial staging with 68Ga-DOTATE PET/CT. 68Ga-DOTATATE PET/CT showed incidental focal increased DOTATATE uptake in the left apical prostate tissue, which was thought to be of benign etiology. Digital rectal examination later was consistent with a palpable nodule along with elevated prostate-specific antigen of 7.0 ng/mL. MRI of prostate demonstrated a 3.8-cm lesion followed by a targeted biopsy that revealed prostatic acinar adenocarcinoma. Chronic inflammatory cell infiltrates were also noted on biopsy, and this may have been the cause of increased DOTATATE uptake seen on 68Ga-DOTATATE PET/CT study.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Biological Transport
  • Biopsy
  • Carcinoma, Acinar Cell / complications
  • Carcinoma, Acinar Cell / diagnostic imaging*
  • Humans
  • Incidental Findings*
  • Liver Neoplasms / complications
  • Liver Neoplasms / secondary*
  • Male
  • Neuroendocrine Tumors / pathology*
  • Organometallic Compounds / metabolism*
  • Positron Emission Tomography Computed Tomography*
  • Prostate / diagnostic imaging
  • Prostate / metabolism
  • Prostatic Neoplasms / complications
  • Prostatic Neoplasms / diagnostic imaging*

Substances

  • Organometallic Compounds
  • gallium Ga 68 dotatate